Abstract
Mushrooms are the sexual organs or fruiting bodies of fungi. Although some mushrooms are considered to be a rich source for nutrients and biologically active compounds, some species are known because of their toxicity that may cause fatalities every year generally due to misidentification. Among thousands of mushroom species, fewer than a hundred are toxic. Mushroom poisoning is associated with different signs and symptoms that are mainly attributed to some active substances belonging to poisonous mushrooms. Most mushroom toxins cause mild or moderate signs and symptoms such as nausea, vomiting, abdominal pain, fever, and headache. However, some species result in severe poisoning. Renal failure, neurotoxicity, hepatotoxicity, rhabdomyolysis, and other toxic effects were identified in toxicity studies with various species.
The toxicity of mushroom is influenced by many factors including genus and species, geographic location, preparation prior to ingestion, and the human’s susceptibility. This chapter is aimed to address various types of mushroom toxins, thus providing some information about their toxic mechanisms, a brief description of the toxicokinetics (absorption, distribution, metabolism, excretion) of mushroom toxins, and management of mushroom poisonings.
References
Barbato M. Poisoning from accidental ingestion of mushrooms. Med J Aust. 1993;158:842–7.
Bedry R, Baudrimont I, Defieux G, Creppy E, Pomies J, Dupon M, et al. Wild mushroom intoxication as a cause of rhabdomyolysis. N Engl J Med. 2001;345:798–802.
Berger K, Guss D. Mycotoxins revisited: part II. J Emerg Med. 2005;28:175–83.
Beuhler M, Graeme K. Overview of mushroom poisoning. In: Brent J, Wallace K, Burkhart K, Phillips S, Donovan, editors. Critical care toxicology. Mosby: Elsevier; 2005. p. 1263–75.
Blayney D, Rosenkranz E, Zettner A. Mushroom poisoning from Chlorophyllum molybdites. West J Med. 1980;132:74–7.
Braun R, Greeff U, Netter K. Liver injury by the false morel poison gyromitrin. Toxicology. 1979;12:155–63.
Brent J, Palmer R. Mushrooms. In: Shnnon M, Borron S, Burns M, editors. Haddad and Winchester clinical management of poisoning and drug overdose. 4th ed. Philadelphia: Saunders Elsevier; 2007. p. 455–72.
Brooks E, Graeme K. Gyromitra mushrooms. In: Brent J, Wallace K, Burkhart K, Phillips S, Donovan, editors. Critical care toxicology. Mosby: Elsevier; 2005. p. 1287–94.
Carlsson A, Henning M, Lindberg P, Martinson P, Trolin G, Waldeck B, et al. On the disulfiram-like effect of coprine, the pharmacologically active principle of Coprinus atramentarius. Acta Pharmacol Toxicol. 1978;42:292–7.
Danel V, Saviu P, Garon D. Main features of Cortinarius spp. poisoning: a literature review. Toxicon. 2001;39:1053–60.
De Haro L, Prost N, David J, Arditti J, Valli M. Syndrome sudorien et muscarinien. Experience de Centre Antipoisons de Marseille. Presse Med. 1999;28:1069e70.
Donnelly M, Wax P. Cyclopeptide-containing mushrooms: deadly Amanita mushrooms. In: Brent J, Wallace K, Burkhart K, Phillips S, Donovan, editors. Critical care toxicology. Mosby: Elsevier; 2005. p. 1277–85.
Enjalbert F, Rapior S, Nouguier-Soulé J, et al. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40:715–57.
French A, Garrettson L. Poisoning with the North American Jack O’Lantern mushroom, Omphalotus illudens. J Toxicol Clin Toxicol. 1988;26:81–8.
Gannett P, Garrett C, Lawson T, et al. Chemical oxidation and metabolism of N-methyl-N-formylhydrazine. Evidence for diazenium and radical intermediates. Food Chem Toxicol. 1991;29:49–56.
Goldfrank L. Mushrooms. In: Goldfrank L, editor. Goldfranks toxicology emergencies. New York: MC Graw-Hill; 2009. p. 1522–36.
Hasler F, Bourquin D, Brenneisen R. Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man. J Pharm Biomed Anal. 2002;30:331–9.
Jaeger A, Jehl F, Flesch F, et al. Kinetics of amatoxins in human poisoning: therapeutic implications. J Toxicol Clin Toxicol. 1993;31:63–80.
Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. “Silymarin”, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 2010;14:308–17.
Karlson-Stiber C, Persson H. Cytotoxic fungi – an overview. Toxicon. 2003;42:339–49.
Leist M, Gantner F, Naumann H, et al. Tumor necrosis factor induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology. 1997;112:923–34.
Lheureux P, Penaloza A, Gris M. Pyridoxine in clinical toxicology: a review. Eur J Emerg Med. 2005;12:78–85.
Lima ADL, Costa Fortes R, Garbi Novaes MRC, Percário S. Poisonous mushrooms; a review of the most common intoxications. Nutr Hosp. 2012;27:402–8.
Lindell T, Weinberg F, Morris P, et al. Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science. 1970;170:447–9.
Mas A. Mushrooms, amatoxins and the liver. J Hepatol. 2005;42:166–9.
Mayer K, Myers R, Lee S. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat. 2005;12:559–67.
Michelot D. Poisoning by Coprinus atramentarius. Nat Toxins. 1992;1:73–80.
Michelot D, Melendez-Howell L. Amanita muscaria: chemistry, biology and ethnomycology. Mycol Res. 2003;107:131–46.
Michelot D, Tebbett I. Poisoning by members of the genus Cortinarius – a review. Mycol Res. 1990;94:289–98.
Michelot D, Toth B. Gyromitra esculenta – a review. J Appl Toxicol. 1991;11:235–43.
Musshoff F, Madea B, Beike J. Hallucinogenic mushrooms on the German market – simple instructions for examination and identification. Forensic Sci Int. 2000;13:389–95.
Nielsen E, Schousboe A, Hansen S. Excitatory amino acids: studies on the biochemical and chemical stability of ibotenic acid and related compounds. J Neurochem. 1985;45:725–31.
Nilson A, Nystrom J, Buvall L, Ebefors K, Bjornson-Granqvist A, Holmdahl J, et al. The fungal nephrotoxin Orellanine simultaneously increases oxidative stress and down-regulates cellular defenses. Free Radic Biol Med. 2008;44:1562–9.
Salhab S. A minireview on mushroom: emphasis on the wild mushroom of Jordan. Jordan Med J. 2007;41:170–8.
Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides. Int J Hepatol. 2012;2012:487480.
Stallard D, Edes T. Muscarinic poisoning from medications and mushrooms. A puzzling symptom complex. Postgrad Med. 1989;85:341–5.
Stormer F, Koller G, Janak K. Ibotenic acid in Amanita muscaria spores and caps. Mycologist. 2004;18:114–7.
Tegzes J, Puschner B. Toxic mushrooms. Vet Clin Small Anim. 2002;32:397–407.
Toth B, Gannett P. Gyromitra esculenta mushroom: a comparative assessment of its carcinogenic potency. In Vitro. 1994;8:999–1002.
Tsujikawa K, Mohri H, Kuwayama K, Miyaguchi H, Iwata Y, Gohda A, et al. Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Sci Int. 2006;164:172–8.
Tsujikawa K, Kuwayama K, Kanamori T, Iwata Y, Inoue H, Yoshida T, et al. Determination of muscimol and ibotenic acid in Amanita mushrooms by high-performance liquid chromatography and liquid-chromatography-tandem mass spectrometry. J Chromatogr. 2007;852:430–5.
Venkataramanan R, Ramachandran V, Komoroski B, et al. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures. Drug Metab Dispos. 2000;28:1270–3.
Villar D, Knight M, Holding J, et al. Treatment of acute isoniazid overdose in dogs. Vet Hum Toxicol. 1995;37:473–7.
Vogel G, Tuchweber B, Trost W, et al. Protection by silibinin against Amanita phalloides intoxication in beagles. Toxicol Appl Pharmacol. 1984;73:355–62.
Ward J, Kapadia K, Brush E, Salhanick S. Amatoxin poisoning: case reports and review of current therapies. J Emerg Med. 2013;44:116–21.
West P, Lindgren J, Horowitz B. Amanita smithiana mushroom ingestion: a case of delayed renal failure and literature review. J Med Toxicol. 2009;5:32–8.
Wieland T. The toxic peptides from Amanita mushrooms. Int J Pept Protein Res. 1983;22:257–76.
Young A. Muscarine-containing mushrooms. In: Spoerke D, Rumack B, editors. Handbook of mushroom poisoning – diagnosis and treatment. Boca Raton: CRC Press; 1994. p. 399–418.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Karimi, G., Razavi, B.M. (2015). Poisonous Mushrooms. In: Gopalakrishnakone, P., Faiz, A., Fernando, R., Gnanathasan, C., Habib, A., Yang, CC. (eds) Clinical Toxinology in Asia Pacific and Africa. Toxinology, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6386-9_42
Download citation
DOI: https://doi.org/10.1007/978-94-007-6386-9_42
Received:
Accepted:
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6385-2
Online ISBN: 978-94-007-6386-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences